Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Growth Disorders | 6 | 2022 | 645 | 1.430 |
Why?
|
Gestational Age | 6 | 2022 | 3493 | 1.280 |
Why?
|
Body Height | 6 | 2022 | 1576 | 1.260 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 2 | 2021 | 159 | 1.220 |
Why?
|
Premature Birth | 7 | 2024 | 1721 | 1.190 |
Why?
|
Birth Weight | 5 | 2022 | 2069 | 0.800 |
Why?
|
Child Development | 5 | 2022 | 2223 | 0.730 |
Why?
|
Tanzania | 9 | 2022 | 1346 | 0.670 |
Why?
|
Dietary Supplements | 11 | 2024 | 3297 | 0.670 |
Why?
|
Anthropometry | 6 | 2022 | 1350 | 0.660 |
Why?
|
Parturition | 1 | 2022 | 441 | 0.640 |
Why?
|
Malnutrition | 2 | 2022 | 625 | 0.630 |
Why?
|
Adolescent Development | 1 | 2021 | 278 | 0.610 |
Why?
|
Microcephaly | 1 | 2022 | 432 | 0.610 |
Why?
|
Intelligence | 1 | 2021 | 920 | 0.540 |
Why?
|
Data Mining | 1 | 2020 | 537 | 0.520 |
Why?
|
HIV | 1 | 2022 | 1604 | 0.510 |
Why?
|
Cholecalciferol | 6 | 2016 | 537 | 0.510 |
Why?
|
Nutritional Status | 3 | 2022 | 1609 | 0.480 |
Why?
|
Pregnancy | 24 | 2024 | 29142 | 0.470 |
Why?
|
Vitamin D Deficiency | 5 | 2015 | 1343 | 0.470 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2015 | 347 | 0.440 |
Why?
|
Executive Function | 1 | 2021 | 1362 | 0.420 |
Why?
|
Infant, Newborn | 15 | 2024 | 25618 | 0.360 |
Why?
|
Weight Gain | 4 | 2023 | 2292 | 0.340 |
Why?
|
Prenatal Care | 2 | 2014 | 1092 | 0.340 |
Why?
|
Infant | 14 | 2023 | 35129 | 0.330 |
Why?
|
Pregnancy Trimester, Third | 6 | 2021 | 571 | 0.320 |
Why?
|
Vitamin D | 4 | 2015 | 3222 | 0.270 |
Why?
|
Infant, Premature | 1 | 2015 | 2044 | 0.270 |
Why?
|
Developing Countries | 6 | 2023 | 2814 | 0.270 |
Why?
|
Vitamins | 5 | 2022 | 1621 | 0.260 |
Why?
|
Public Health | 1 | 2018 | 2603 | 0.250 |
Why?
|
HIV Infections | 4 | 2023 | 16718 | 0.240 |
Why?
|
World Health Organization | 2 | 2022 | 1318 | 0.230 |
Why?
|
Pregnancy Outcome | 6 | 2023 | 2796 | 0.220 |
Why?
|
Randomized Controlled Trials as Topic | 8 | 2024 | 9960 | 0.200 |
Why?
|
Infant, Small for Gestational Age | 2 | 2022 | 440 | 0.200 |
Why?
|
Growth Charts | 1 | 2022 | 61 | 0.200 |
Why?
|
Fetal Macrosomia | 1 | 2022 | 124 | 0.200 |
Why?
|
Bangladesh | 4 | 2015 | 687 | 0.190 |
Why?
|
Diet | 2 | 2021 | 7937 | 0.180 |
Why?
|
Body Weight | 3 | 2022 | 4666 | 0.180 |
Why?
|
Female | 29 | 2024 | 380197 | 0.180 |
Why?
|
Intelligence Tests | 1 | 2021 | 505 | 0.180 |
Why?
|
Pregnancy Complications | 4 | 2022 | 2862 | 0.170 |
Why?
|
Child, Preschool | 11 | 2023 | 40992 | 0.170 |
Why?
|
Calcium | 4 | 2024 | 5757 | 0.170 |
Why?
|
Child | 13 | 2022 | 77679 | 0.170 |
Why?
|
Anemia | 2 | 2022 | 1504 | 0.170 |
Why?
|
Burkina Faso | 3 | 2023 | 88 | 0.160 |
Why?
|
Micronutrients | 1 | 2021 | 375 | 0.160 |
Why?
|
Body Mass Index | 5 | 2023 | 12718 | 0.160 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2013 | 3923 | 0.160 |
Why?
|
Education | 1 | 2021 | 543 | 0.160 |
Why?
|
Lactones | 1 | 2021 | 329 | 0.160 |
Why?
|
Sulfones | 1 | 2021 | 437 | 0.160 |
Why?
|
Folic Acid | 2 | 2022 | 1300 | 0.160 |
Why?
|
Growth and Development | 1 | 2018 | 52 | 0.160 |
Why?
|
Humans | 39 | 2024 | 744220 | 0.150 |
Why?
|
Temperature | 1 | 2023 | 2206 | 0.150 |
Why?
|
Infant, Low Birth Weight | 1 | 2021 | 850 | 0.140 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2021 | 489 | 0.130 |
Why?
|
Cathelicidins | 1 | 2014 | 80 | 0.120 |
Why?
|
Pre-Eclampsia | 1 | 2024 | 1200 | 0.120 |
Why?
|
Cohort Studies | 6 | 2022 | 40559 | 0.120 |
Why?
|
Prospective Studies | 7 | 2023 | 53280 | 0.110 |
Why?
|
Leptin | 1 | 2021 | 1599 | 0.110 |
Why?
|
Anthelmintics | 1 | 2013 | 62 | 0.110 |
Why?
|
Poverty | 2 | 2021 | 2660 | 0.110 |
Why?
|
Epidemiologic Methods | 1 | 2018 | 1365 | 0.110 |
Why?
|
Linear Models | 2 | 2021 | 5953 | 0.110 |
Why?
|
Income | 1 | 2021 | 1913 | 0.110 |
Why?
|
Socioeconomic Factors | 2 | 2018 | 7784 | 0.100 |
Why?
|
Growth | 1 | 2013 | 376 | 0.100 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2014 | 378 | 0.100 |
Why?
|
Reference Values | 2 | 2015 | 4982 | 0.100 |
Why?
|
Kenya | 1 | 2013 | 685 | 0.090 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2022 | 2026 | 0.090 |
Why?
|
Geographic Information Systems | 1 | 2013 | 281 | 0.090 |
Why?
|
Nutrition Assessment | 1 | 2013 | 723 | 0.090 |
Why?
|
Models, Theoretical | 1 | 2021 | 3591 | 0.090 |
Why?
|
Office Visits | 1 | 2013 | 598 | 0.080 |
Why?
|
Phagocytosis | 1 | 2014 | 1538 | 0.080 |
Why?
|
Fetal Blood | 4 | 2014 | 1317 | 0.070 |
Why?
|
Fetus | 1 | 2014 | 1880 | 0.070 |
Why?
|
Antimalarials | 1 | 2013 | 907 | 0.070 |
Why?
|
Immunologic Factors | 1 | 2014 | 1582 | 0.060 |
Why?
|
Research Design | 1 | 2021 | 5987 | 0.060 |
Why?
|
Mothers | 1 | 2015 | 2165 | 0.060 |
Why?
|
Longitudinal Studies | 4 | 2023 | 13990 | 0.060 |
Why?
|
Iron | 2 | 2022 | 1774 | 0.060 |
Why?
|
Age Factors | 1 | 2021 | 18367 | 0.060 |
Why?
|
Male | 7 | 2022 | 350027 | 0.060 |
Why?
|
Double-Blind Method | 5 | 2016 | 12035 | 0.060 |
Why?
|
Patient Education as Topic | 1 | 2013 | 2277 | 0.060 |
Why?
|
Malaria | 1 | 2013 | 1239 | 0.050 |
Why?
|
Adolescent | 6 | 2022 | 85759 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2022 | 39045 | 0.050 |
Why?
|
India | 2 | 2021 | 2199 | 0.050 |
Why?
|
Young Adult | 6 | 2023 | 56436 | 0.050 |
Why?
|
Adult | 11 | 2023 | 214035 | 0.050 |
Why?
|
Algorithms | 1 | 2021 | 13885 | 0.050 |
Why?
|
Databases, Factual | 1 | 2015 | 7730 | 0.050 |
Why?
|
Middle East | 1 | 2020 | 219 | 0.050 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 25043 | 0.040 |
Why?
|
Macrophages | 1 | 2014 | 5657 | 0.040 |
Why?
|
Patient Acceptance of Health Care | 1 | 2013 | 3023 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12244 | 0.040 |
Why?
|
Stillbirth | 1 | 2021 | 346 | 0.040 |
Why?
|
Pregnancy Trimester, Second | 1 | 2021 | 732 | 0.040 |
Why?
|
Africa South of the Sahara | 1 | 2020 | 724 | 0.040 |
Why?
|
Seasons | 1 | 2023 | 1494 | 0.040 |
Why?
|
Biomedical Research | 1 | 2013 | 3311 | 0.040 |
Why?
|
Pregnant Women | 1 | 2022 | 568 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2016 | 4929 | 0.040 |
Why?
|
Morbidity | 1 | 2021 | 1769 | 0.030 |
Why?
|
United States | 1 | 2023 | 69867 | 0.030 |
Why?
|
Hypercalciuria | 1 | 2014 | 31 | 0.030 |
Why?
|
Europe | 1 | 2020 | 3339 | 0.030 |
Why?
|
Social Class | 1 | 2021 | 1999 | 0.030 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2014 | 362 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2016 | 10949 | 0.030 |
Why?
|
Maternal-Fetal Exchange | 1 | 2014 | 455 | 0.030 |
Why?
|
Hypercalcemia | 1 | 2014 | 407 | 0.030 |
Why?
|
Macrophage Activation | 1 | 2014 | 558 | 0.020 |
Why?
|
Family | 1 | 2022 | 3148 | 0.020 |
Why?
|
Serum Albumin | 1 | 2013 | 676 | 0.020 |
Why?
|
Risk Factors | 3 | 2023 | 72280 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2022 | 5396 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2014 | 1157 | 0.020 |
Why?
|
Creatinine | 1 | 2013 | 1919 | 0.020 |
Why?
|
Administration, Oral | 1 | 2014 | 3913 | 0.020 |
Why?
|
Parathyroid Hormone | 1 | 2013 | 1801 | 0.020 |
Why?
|
Disease Progression | 1 | 2022 | 13280 | 0.020 |
Why?
|
Incidence | 1 | 2023 | 20945 | 0.020 |
Why?
|
Cognition | 1 | 2022 | 6765 | 0.020 |
Why?
|
Homeostasis | 1 | 2014 | 3339 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2014 | 2958 | 0.010 |
Why?
|
Circadian Rhythm | 1 | 2013 | 2624 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 19227 | 0.010 |
Why?
|
Prevalence | 1 | 2014 | 15226 | 0.010 |
Why?
|
Obesity | 1 | 2018 | 12742 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 40063 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2014 | 63119 | 0.000 |
Why?
|
Concepts
(145)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_